SAMANTHA GALUCCI: Open Payments
NPI 1366224297 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,664 in 104 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,280 · 2025 $1,664
Food & beverage: $1,564Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $455 |
| Janssen Biotech, Inc. | 12 | $289 |
| Incyte Corporation | 9 | $143 |
| Galderma Laboratories, L.P. | 8 | $135 |
| UCB, Inc. | 7 | $122 |
| Amgen Inc. | 5 | $87 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 4 | $71 |
| Lilly USA, LLC | 3 | $55 |
| Organogenesis Inc. | 1 | $43 |
Products named: SKYRIZI, TREMFYA, RINVOQ, OPZELURA, NEMLUVIO, Bimzelx, DUPIXENT, OTEZLA.
Industry payments across NJ — which companies pay providers there.
